<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82264">
  <stage>Registered</stage>
  <submitdate>5/09/2007</submitdate>
  <approvaldate>19/09/2007</approvaldate>
  <actrnumber>ACTRN12607000468426</actrnumber>
  <trial_identification>
    <studytitle>Predictors of a sustained Response to Exercise Training in Patients with Type2 Diabetes: A tele-monitoring Study</studytitle>
    <scientifictitle>Predictors of a sustained response to exercise training in patients with type2 diabetes: A tele-monitoring study.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Type 2 Dibetes mellitus</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The exercise program will encourage patients to complete three hours of exercise per week. This volume of activity has been shown to be superior over a program of 115 minutes per week in improving insulin sensitivity. Patients will be instructed to complete 45-minute walks, four times weekly, totalling 180 minutes (3hours) per week. The absolute volume of exercise will be considered rather than the precise combination of duration and frequency. Other combinations of exercise frequency and duration (e.g. three one hour exercise sessions) have been demonstrated to be as effective in generating health benefits. The exercise intensity will be governed by the heart rate as per heart rate monitors and patients will be fully versed in the importance of adhering to the correct exercise intensity range.</interventions>
    <comparator>Exercise with heart rate monitor versus exercise with no heart rate monitor.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Blood test for HbA1C mmol/l</outcome>
      <timepoint>0,6,12 months.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cardiorespiratory fitness test,arterial function,endothelial function,cardiovascular function,Quality of life, number of visit to general paractitioner and hospitalitation</outcome>
      <timepoint>0,6,12 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>type 2 DM patients based on fasting glucose&gt;7.0 and Body mass index &gt;27 will be recruited.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Patients with unstable angina,Chornic obstructive pulmonary disease or inability to exercise will ungergo an introductory program of aerobic and reistance tarining before being randomized.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>Stratified allocation. Factors such as centre, age gender or previous treatment are used for the stratification</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>14/09/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>220</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Bond University</primarysponsorname>
    <primarysponsoraddress>Faculty of Health Science &amp; Medicine
Gold Coast
QLD 4229</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Novo Nordisk</fundingname>
      <fundingaddress>level 3, Norwest Quay
21 Solent Circuit
Baulkham Hills
NSW 2153</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Gold Coast Hospital</sponsorname>
      <sponsoraddress>8 High Street
South Port
QLD 4215</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bond University</ethicname>
      <ethicaddress>Bond University Research &amp; Consultancy Servies(BURCS)</ethicaddress>
      <ethicapprovaldate>21/08/2007</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>A/Prof. Neil Smart</name>
      <address>Faculty of Health Science &amp; Medicine
Bond University
QLD 4229</address>
      <phone>(07) 5595 4453</phone>
      <fax>(07) 5595 4122</fax>
      <email>nsmart@bond.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Neil Smart</name>
      <address>Bond University
Faculty of Heath Sciences &amp; Medicine
Bond University 
Gold Coast
QLD 4229</address>
      <phone>(07) 5595 4453</phone>
      <fax>(07) 5595 4453</fax>
      <email>nsmart@bond.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>A/Prof. Neil Smart</name>
      <address>Faculty of Health Science &amp; Medicine Bond University Gold Coast QLD 4229</address>
      <phone>(07) 5595 4453</phone>
      <fax>(07) 5595 4122</fax>
      <email>nsmart@bond.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>